| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 01/30/2003 | CA2395992A1 Method for the screening of compounds that inhibit the interaction between a proline-rich peptide and a sh3 domain comprising peptide |
| 01/29/2003 | EP1279678A1 Gag antigen and other orf fragments of lav virus. Use for the detection of lav infection and in immunogenic compositions |
| 01/29/2003 | EP1279676A1 Porphyrin derivatives for photodynamic therapy |
| 01/29/2003 | EP1279674A2 Acetylenic ortho-sulfonamido and phosphinic acid amido bicyclic heteroaryl hydroxamic acids as TACE inhibitors |
| 01/29/2003 | EP1279406A1 Transporters and drug delivery system by using the same |
| 01/29/2003 | EP1279404A1 Use of HIV-1 tat, fragments or derivatives thereof, to target or to activate antigen-presenting cells, to deliver cargo molecules for vaccination or to treat other diseases |
| 01/29/2003 | EP1279402A1 Coated granules of allylamine-or benzylamine-anti-mycotics, process for preparation thereof and orodispersible tablets containing said coated granules |
| 01/29/2003 | EP1278881A1 Hybrid glycosylated products and their production and use |
| 01/29/2003 | EP1278869A2 Proteases |
| 01/29/2003 | EP1278868A2 Novel mutated form of arginine deiminase |
| 01/29/2003 | EP1278859A2 Human protein kinases and protein kinase-like enzymes |
| 01/29/2003 | EP1278856A2 Immunogenic pneumococcal protein and vaccine compositions thereof |
| 01/29/2003 | EP1278853A2 Listeria monocytogenes genome, polypeptides and uses |
| 01/29/2003 | EP1278846A2 Cytoskeleton-associated proteins |
| 01/29/2003 | EP1278845A2 Cellular regulators of infectious agents and methods of use |
| 01/29/2003 | EP1278843A2 Rna metabolism proteins |
| 01/29/2003 | EP1278838A2 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 01/29/2003 | EP1278829A2 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema |
| 01/29/2003 | EP1278778A2 Modified peptides, comprising an fc domain, as therapeutic agents |
| 01/29/2003 | EP1278767A1 Albumin fusion proteins |
| 01/29/2003 | EP1278764A2 Compounds and methods for the treatment and prevention of bacterial infection |
| 01/29/2003 | EP1278763A1 3-nitrogen-6,7-dioxygen steroids and uses related thereto |
| 01/29/2003 | EP1278759A1 Bis-(n,n'-bis-(2-haloethyl)amino) phosphoramidates as antitumor agents |
| 01/29/2003 | EP1278755A2 Azole compounds as therapeutic agents for fungal infections |
| 01/29/2003 | EP1278751A1 Tricyclic fused pyridine and pyrimidine derivatives as crf receptor antagonists |
| 01/29/2003 | EP1278749A1 USE OF 5-THIO-, SULFINYL- AND SULFONYLPYRAZOLO 3,4-b]-PYRIDINES AS CYCLIN DEPENDENT KINASE INHIBITORS |
| 01/29/2003 | EP1278748A2 Inhibitors of human phosphatidyl-inositol 3-kinase delta |
| 01/29/2003 | EP1278743A1 Novel anti-infectives |
| 01/29/2003 | EP1278742A1 Chromenylmethylpyrimidinediamines as antibacterial agents |
| 01/29/2003 | EP1278732A1 1-aroyl-piperidinyl benzamidines |
| 01/29/2003 | EP1278549A2 Cyclodextrin containing glycopeptide antibiotic compositions |
| 01/29/2003 | EP1278548A2 Lipopolysaccharide-conjugate vaccine for sepsis treatment |
| 01/29/2003 | EP1278546A1 Combination therapy of respiratory diseases using antibodies and anti-inflammatory agents |
| 01/29/2003 | EP1278545A1 Combination therapy of respiratory diseases using antibodies |
| 01/29/2003 | EP1278544A2 Albumin fusion proteins |
| 01/29/2003 | EP1278542A2 Molecular antigen arrays and vaccines |
| 01/29/2003 | EP1278541A1 Improved immunogenicity using a combination of dna and vaccinia virus vector vaccines |
| 01/29/2003 | EP1278534A1 Methods and compositions for impairing multiplication of hiv-1 |
| 01/29/2003 | EP1278531A1 Preparation for topically treating manifestations caused by virus infections |
| 01/29/2003 | EP1278528A1 Nucleoside analogs with carboxamidine-modified bicyclic base |
| 01/29/2003 | EP1278527A1 Derivatives of polyene macrolides and preparation and use thereof |
| 01/29/2003 | EP1278515A1 Pharmaceutical formulation comprising carrier beads coated with a layer of valaciclovir |
| 01/29/2003 | EP1117669B1 Antiviral purine derivatives |
| 01/29/2003 | EP1102761B1 Cyclopentabenzofuran derivatives and their use |
| 01/29/2003 | EP1040107B1 6-o-alkyl derivatives of erythronolide b |
| 01/29/2003 | EP1036074B1 S-oxide tetrahydrothiopyran phenyloxazolidinones |
| 01/29/2003 | EP1033369B1 5H-PYRANO [2,3-d:6,5-d']DIPYRIMIDINE DERIVATIVES HAVING AN ANTIBACTERIAL, ANTIVIRAL AND IMMUNO-MODULATING ACTIVITY |
| 01/29/2003 | EP1030836B1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity |
| 01/29/2003 | EP1002110B1 Immune responses against hpv antigens elicited by compositions comprising an hpv antigen and a stress protein or an expression vector capable of expression of these proteins |
| 01/29/2003 | EP0973735B1 Polyaromatic antiviral compositions |
| 01/29/2003 | EP0874863B1 3-deoxy-3-descladinose derivatives of erythromycins a and b |
| 01/29/2003 | EP0641795B9 Carbapenem derivative |
| 01/29/2003 | CN1394206A Novel vitamin D analogues |
| 01/29/2003 | CN1394202A Picolinic acid derivatives and their use as fungicides |
| 01/29/2003 | CN1394201A Substituted glutarimides and use thereof IL-12 production inhibitors |
| 01/29/2003 | CN1393246A Disui Dan |
| 01/29/2003 | CN1393243A Chinese medicine for treating tuberculosis |
| 01/29/2003 | CN1393240A Antibacterial and anti-inflammatory medicine and its preparing process |
| 01/29/2003 | CN1393234A 'Jingema' honeyed cream for antipyresis and detoxication |
| 01/29/2003 | CN1393219A Application of tetracyclic coumarin compounds in preparing anti-HIV medicine |
| 01/29/2003 | CN1099889C Enema liquor for woman pelvic inflammation |
| 01/29/2003 | CN1099875C Dermatosis treating medicine |
| 01/29/2003 | CN1099870C Application of Gerd mycomycin in preparing novel grand spectrum anti-virus medicine |
| 01/28/2003 | US6512166 Combinations of fungal cell wall degrading enzyme and fungal cell membrane affecting compound |
| 01/28/2003 | US6512116 No drug resistance; intravenous |
| 01/28/2003 | US6512112 Useful as prodrugs, easily convert to parent amine in vivo; antibiotic activity versus gram negative aerobic and anaerobic bacteria |
| 01/28/2003 | US6512104 Interleukin-1β converting enzyme like cysteine protease |
| 01/28/2003 | US6512101 Branched hydrazone linkers |
| 01/28/2003 | US6512011 Treating or preventing a recurrence of a herpes viral infection comprising administering an effective amount of bupropion or a physiologically acceptable salt, solvate or enantiomer of; possibly with acyclovir |
| 01/28/2003 | US6512006 Novel 3-position Nitrogen substituted 6,6- disubstituted-5, 6-dihydropyrones and related compounds possess antiviral properties |
| 01/28/2003 | US6511997 For treatment of a disease associated with tumor necrosis factor alpha, interleukin 1, interleukin 6 or cyclooxygenase II; such as irritable bowel disease |
| 01/28/2003 | US6511983 Pharmaceutical combination of antiviral agents |
| 01/28/2003 | US6511978 Pyrrole derivatives useful for farnesyl transferase inhibitors and their preparations |
| 01/28/2003 | US6511972 Stable oral pharmaceutical formulations comprising amoxycillin trihydrate and potassium clavulanate |
| 01/28/2003 | US6511965 Ether type lipid A 1-carboxylic acid analogs |
| 01/28/2003 | US6511962 Intermediates useful for synthesizing laspartomycin derivatives as well as the laspartomycin derivatives |
| 01/28/2003 | US6511813 Identifying compound which inhibits peptide bond reaction of a complex formed by interaction of EFP, N-formyl methionyl-tRNA, 30S subunit, 50S subunit, an mRNA containing AUG sequence, initiation factors 1, 2, 3, and peptide bond donor |
| 01/28/2003 | US6511807 Carbohydrate ligand that specifically binds to a leczyme; nucleic acid sequence encoding a nonclassical MHC class I heavy chain; ability to associate with a beta 2 microglobulin; major histocompatibility complex transplantation molecules |
| 01/28/2003 | US6511681 Solubility and bioavailability of azole antifungal medicaments |
| 01/28/2003 | US6511667 Attenuated dengue-2 virus vaccine |
| 01/28/2003 | US6511662 Treatment of cytomegalovirus using aminopeptidase N |
| 01/28/2003 | US6511661 A probiotic formulation of Escherichia coli strain BU-230-98 ATCC Deposit No. 20226 (DSM 12799); containing at least one volatile fraction (VF) of a plant extract |
| 01/28/2003 | CA2318432C The use of isolated domains of type iv collagen to modify cell and tissue interactions |
| 01/28/2003 | CA2258906C Amides |
| 01/23/2003 | WO2003006996A2 Natural ligand of gpcr chemr23 and uses thereof |
| 01/23/2003 | WO2003006691A1 Methods for genetic modification of hematopoietic progenitor cells and uses of the modified cells |
| 01/23/2003 | WO2003006636A1 Reduction of the stimulatory capacity of antigen-presenting cells |
| 01/23/2003 | WO2003006634A2 Use of oxidised lipoproteins for differentiation of precursor cells into mature dendritic cells |
| 01/23/2003 | WO2003006628A2 Nad synthetase inhibitors and uses thereof |
| 01/23/2003 | WO2003006612A2 Production of transduced hematopoietic progenitor cells |
| 01/23/2003 | WO2003006519A1 Polymers for oral use and compositions for oral use |
| 01/23/2003 | WO2003006501A2 G-csf conjugates |
| 01/23/2003 | WO2003006495A2 Human papillomavirus e2 transactivation domain/inhibitor co-crystal and x-ray coordinates defining the inhibitor-binding pocket |
| 01/23/2003 | WO2003006492A2 Biologically active peptides |
| 01/23/2003 | WO2003006490A1 Bridged bicyclic serine protease inhibitors |
| 01/23/2003 | WO2003006478A1 Oligonucleotide-containing pharmacological compositions and their use |
| 01/23/2003 | WO2003006477A1 IN VIVO PRODUCTION OF SMALL INTERFERING RNAs THAT MEDIATE GENE SILENCING |
| 01/23/2003 | WO2003006456A1 4-substituted-picolinic acid amide derivates useful as fungicides |
| 01/23/2003 | WO2003006441A1 Crystalline thiazine oxazolidinones |
| 01/23/2003 | WO2003006440A2 Amide-containing compound having improved solubility and method of improving the solubility of an amide-containing compound |